Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 3-4/2016

Open Access 01-12-2016

p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice

Authors: Milou Tenhagen, Sjoerd Klarenbeek, Tanya M. Braumuller, Ilse Hofmann, Petra van der Groep, Natalie ter Hoeve, Elsken van der Wall, Jos Jonkers, Patrick W. B. Derksen

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 3-4/2016

Login to get access

Abstract

Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC). E-cadherin loss leads to dismantling of the adherens junction and subsequent translocation of p120-catenin (p120) to the cytosol and nucleus. Although p120 is critical for the metastatic potential of ILC through the regulation of Rock-dependent anoikis resistance, it remains unknown whether p120 also contributes to ILC development. Using genetically engineered mouse models with mammary gland-specific inactivation of E-cadherin, p120 and p53, we demonstrate that ILC formation induced by E-cadherin and p53 loss is severely impaired upon concomitant inactivation of p120. Tumors that developed in the triple-knockout mice were mostly basal sarcomatoid carcinomas that displayed overt nuclear atypia and multinucleation. In line with the strong reduction in ILC incidence in triple-knockout mice compared to E-cadherin and p53 double-knockout mice, no functional redundancy of p120 family members was observed in mouse ILC development, as expression and localization of ARVCF, p0071 or δ-catenin was unaltered in ILCs from triple-knockout mice. In conclusion, we show that loss of p120 in the context of the p53-deficient mouse models is dominant over E-cadherin inactivation and its inactivation promotes the development of basal, epithelial-to-mesenchymal-transition (EMT)-type invasive mammary tumors.
Appendix
Available only for authorised users
Literature
2.
go back to reference Christgen M, Derksen PW. Lobular breast cancer: molecular basis, mouse and cellular models. Breast Cancer Res. 2015;17:1–9.CrossRef Christgen M, Derksen PW. Lobular breast cancer: molecular basis, mouse and cellular models. Breast Cancer Res. 2015;17:1–9.CrossRef
3.
go back to reference Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76:1131–3.CrossRefPubMedPubMedCentral Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76:1131–3.CrossRefPubMedPubMedCentral
4.
go back to reference Berx G, Nollet F, De LWJF, Vijver MJ, De V, Cornelisse C, Van RF. E-cadherin as a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107–15.PubMedPubMedCentral Berx G, Nollet F, De LWJF, Vijver MJ, De V, Cornelisse C, Van RF. E-cadherin as a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107–15.PubMedPubMedCentral
5.
go back to reference Sarrió D, Pérez-Mies B, Hardisson D, Moreno-Bueno G, Suárez A, Cano A, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene. 2004;23:3272–83.CrossRefPubMed Sarrió D, Pérez-Mies B, Hardisson D, Moreno-Bueno G, Suárez A, Cano A, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene. 2004;23:3272–83.CrossRefPubMed
6.
go back to reference Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRefPubMed Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRefPubMed
7.
go back to reference Grady WM, Willis J, Guilford PJ, Dunbier a K, Toro TT, Lynch H, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16–7.CrossRefPubMed Grady WM, Willis J, Guilford PJ, Dunbier a K, Toro TT, Lynch H, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16–7.CrossRefPubMed
9.
go back to reference Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev. 2002;115:53–62.CrossRefPubMed Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev. 2002;115:53–62.CrossRefPubMed
10.
go back to reference Derksen PWB, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006;10:437–49.CrossRefPubMed Derksen PWB, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006;10:437–49.CrossRefPubMed
11.
go back to reference Derksen PWB, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J, et al. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech. 2011;4:347–58.CrossRefPubMedPubMedCentral Derksen PWB, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J, et al. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech. 2011;4:347–58.CrossRefPubMedPubMedCentral
12.
go back to reference Harris TJC, Tepass U. Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol. 2010;11:502–14.CrossRefPubMed Harris TJC, Tepass U. Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol. 2010;11:502–14.CrossRefPubMed
13.
go back to reference Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol. 2002;159:465–76.CrossRefPubMedPubMedCentral Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol. 2002;159:465–76.CrossRefPubMedPubMedCentral
15.
go back to reference Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S. Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol. 2004;164:2269–78.CrossRefPubMedPubMedCentral Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S. Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol. 2004;164:2269–78.CrossRefPubMedPubMedCentral
16.
go back to reference Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol. 2007;31:427–37.CrossRefPubMed Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol. 2007;31:427–37.CrossRefPubMed
17.
go back to reference Schackmann RCJ, Van AM, Haarhuis JHI, Vlug EJ, Halim VA, Roodhart JML, et al. Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest. 2011;121:3176–88.CrossRefPubMedPubMedCentral Schackmann RCJ, Van AM, Haarhuis JHI, Vlug EJ, Halim VA, Roodhart JML, et al. Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest. 2011;121:3176–88.CrossRefPubMedPubMedCentral
18.
go back to reference van de Ven RAH, Tenhagen M, Meuleman W, van Riel JJG, Schackmann RCJ, Derksen PWB. Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through kaiso-dependent Wnt11 expression. Dis Model Mech. 2015;8:373–84.CrossRefPubMedPubMedCentral van de Ven RAH, Tenhagen M, Meuleman W, van Riel JJG, Schackmann RCJ, Derksen PWB. Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through kaiso-dependent Wnt11 expression. Dis Model Mech. 2015;8:373–84.CrossRefPubMedPubMedCentral
19.
go back to reference Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70.CrossRef Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70.CrossRef
20.
go back to reference Turashvili G, Turashvili G, Bouchal J, Bouchal J, Burkadze G, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Proteomics of invasive ductal and lobular breast carcinomas. Biomed Pap. 2005;149:57–62.CrossRef Turashvili G, Turashvili G, Bouchal J, Bouchal J, Burkadze G, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Proteomics of invasive ductal and lobular breast carcinomas. Biomed Pap. 2005;149:57–62.CrossRef
21.
go back to reference Carnahan RH, Rokas A, Gaucher E a, Reynolds AB. The molecular evolution of the p120-catenin subfamily and its functional associations. PLoS One. 2010;5:e15747.CrossRefPubMedPubMedCentral Carnahan RH, Rokas A, Gaucher E a, Reynolds AB. The molecular evolution of the p120-catenin subfamily and its functional associations. PLoS One. 2010;5:e15747.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Schackmann RCJ, Klarenbeek S, Vlug EJ, Stelloo S, van Amersfoort M, Tenhagen M, et al. Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res. 2013;73:4937–49.CrossRefPubMed Schackmann RCJ, Klarenbeek S, Vlug EJ, Stelloo S, van Amersfoort M, Tenhagen M, et al. Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res. 2013;73:4937–49.CrossRefPubMed
24.
go back to reference Davis MA, Reynolds AB. Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell. 2006;10:21–31.CrossRefPubMed Davis MA, Reynolds AB. Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell. 2006;10:21–31.CrossRefPubMed
25.
go back to reference Cardiff RD, Kenney N. Mouse mammary tumor biology: A Short History. Adv Cancer Res 2007;98:53–116.CrossRefPubMed Cardiff RD, Kenney N. Mouse mammary tumor biology: A Short History. Adv Cancer Res 2007;98:53–116.CrossRefPubMed
26.
go back to reference Peppercorn J, Perou CM, Carey LA. Molecular subtypes in breast cancer evaluation and management: Divide and conquer. Cancer Investig. 2008;26:1–10.CrossRef Peppercorn J, Perou CM, Carey LA. Molecular subtypes in breast cancer evaluation and management: Divide and conquer. Cancer Investig. 2008;26:1–10.CrossRef
27.
go back to reference Dillon DA, D’Aquila T, Reynolds AB, Fearon ER, Rimm DL. The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol. 1998;152:75–82.PubMedPubMedCentral Dillon DA, D’Aquila T, Reynolds AB, Fearon ER, Rimm DL. The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol. 1998;152:75–82.PubMedPubMedCentral
28.
go back to reference Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis a J, Giannopoulou I, Keramopoulos A, Davaris P, et al. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology. 2002;40:536–46.CrossRefPubMed Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis a J, Giannopoulou I, Keramopoulos A, Davaris P, et al. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology. 2002;40:536–46.CrossRefPubMed
29.
go back to reference Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, et al. Altered expression of p120catenin predicts poor outcome in invasive breast cancer. J Cancer Res Clin Oncol. 2010;136:1377–87.CrossRefPubMed Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, et al. Altered expression of p120catenin predicts poor outcome in invasive breast cancer. J Cancer Res Clin Oncol. 2010;136:1377–87.CrossRefPubMed
30.
go back to reference Anastasiadis PZ, Reynolds AB. Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol. 2001;13:604–10.CrossRefPubMed Anastasiadis PZ, Reynolds AB. Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol. 2001;13:604–10.CrossRefPubMed
31.
go back to reference Daniel JM, Reynolds AB, B. The catenin p120(ctn) interacts with kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999;19:3614–3623. Daniel JM, Reynolds AB, B. The catenin p120(ctn) interacts with kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999;19:3614–3623.
32.
go back to reference van Roy FM, McCrea PD. A role for kaiso-p120ctn complexes in cancer? Nat Rev Cancer. 2005;5:956–64.CrossRefPubMed van Roy FM, McCrea PD. A role for kaiso-p120ctn complexes in cancer? Nat Rev Cancer. 2005;5:956–64.CrossRefPubMed
33.
go back to reference Kurley SJ, Bierie B, Carnahan RH, Lobdell NA, Davis MA, Hofmann I, et Al. P120-catenin Is Essential for Terminal End Bud Function and Mammary Morphogenesis. Development 2012;1734:1724–1734 Kurley SJ, Bierie B, Carnahan RH, Lobdell NA, Davis MA, Hofmann I, et Al. P120-catenin Is Essential for Terminal End Bud Function and Mammary Morphogenesis. Development 2012;1734:1724–1734
Metadata
Title
p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice
Authors
Milou Tenhagen
Sjoerd Klarenbeek
Tanya M. Braumuller
Ilse Hofmann
Petra van der Groep
Natalie ter Hoeve
Elsken van der Wall
Jos Jonkers
Patrick W. B. Derksen
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 3-4/2016
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-016-9358-3

Other articles of this Issue 3-4/2016

Journal of Mammary Gland Biology and Neoplasia 3-4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine